BioForce Nanosciences Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BFNH research report →
Price Chart
About the company
BioForce Nanosciences Holdings, Inc. (BFNH) specializes in providing natural vitamins, minerals, and a variety of other nutritional supplements, along with powders and beverages, intended for individuals across all age demographics. The firm also operates in the private label market, collaborating with both distributors and production partners.
- CEO
- Richard James Kaiser
- IPO
- 2007
- Employees
- 3
- HQ
- Virginia Beach, VA, US
Get TickerSpark's AI analysis on BFNH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $266.38M
- P/E
- -2646.67
- PEG
- -12.93
- P/S
- 0.00
- P/B
- 115.63
- EV/EBITDA
- -434.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -84.02%
- ROIC
- -26.65%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-489,951
- Net Income
- $-1,291,951-163.4%
- EPS
- $-0.04-131.5%
- OCF Growth
- -6.4%
- FCF Growth
- -6.4%
- Beta
- -0.43
- RSI (14)
- 52
No earnings-call transcripts are available for BFNH yet.
- Free Float
- 14.4%
- Shares Outstanding
- 33.55M
- Float Shares
- 4.83M
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 22, 26 | Nexus Capital Investments, Inc. | other | 0 |
| Aug 31, 26 | Mager Scott | other | 0 |
| Apr 20, 26 | Ferguson Merle | other | 4,132,000 |
| Apr 20, 26 | Ferguson Merle | other | 20,580,000 |
| Apr 22, 26 | Ferguson Merle | sell | 26,700,000 |
| Aug 31, 26 | KAISER RICHARD KAISER | other | 316,909 |
| Apr 20, 26 | KAISER RICHARD KAISER | other | 4,132,000 |
| Aug 20, 26 | KAISER RICHARD KAISER | other | 38,462 |
| Oct 18, 23 | Ferguson Merle | other | 1,400,000 |
| Oct 17, 23 | Ferguson Merle | other | 1,470,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BFNH coverage
Recent articles, reports, and earnings notes.
No research on BFNH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BFNH report →